uspto-grants-2014_09
uspto-grants-2014_09 · 10.6084/m9.figshare.5104873.v1 · US08835443B2
查看条件与参与物IDENTITY
COMPUTED
PROPERTIES
679000
679.0 mg/mL
135
135 °C
Solid
3.12 (at 20 °C)
GHS
This chemical does not meet GHS hazard criteria for 5.4% (3 of 56) of reports.
Warning
H315 (94.6%): Causes skin irritation [Warning Skin corrosion/irritation];H319 (94.6%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (92.9%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 56 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Reported as not meeting GHS hazard criteria per 3 of 56 reports by companies.;There are 5 notifications provided by 53 of 56 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
HAZARDS
Skin Irrit. 2 (94.6%);Eye Irrit. 2 (94.6%);STOT SE 3 (92.9%)
Skin Irrit. 2 (100%);Eye Irrit. 2 (100%);STOT SE 3 (100%)
TOXICITY
Chronically high levels of methylmalonic acid are associated with at least 5 inborn errors of metabolism including: Malonyl CoA decarboxylase deficiency, Malonic Aciduria, Methylmalonate Semialdehyde Dehydrogenase Deficiency, Methylmalonic Aciduria and Methylmalonic Aciduria Due to Cobalamin-Related Disorders.
Methylmalonic acid is a vital intermediate in the metabolism of fat and protein. Abnormalities in methylmalonic acid metabolism lead to methylmalonic aciduria. This metabolic disease is attributed to a block in the enzymatic conversion of methylmalonyl CoA to succinyl CoA. Accumulation of Methylmalonic acid in the body has been shown to be toxic.
No indication of carcinogenicity to humans (not listed by IARC).
PHARMACOLOGY
Kidney;Liver;Placenta
Cytoplasm
2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency;3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency;3-hydroxyisobutyric acid dehydrogenase deficiency;3-hydroxyisobutyric aciduria;3-Methylcrotonyl Coa Carboxylase Deficiency Type I;3-Methylglutaconic Aciduria Type I;3-Methylglutaconic Aciduria Type III;3-Methylglutaconic Aciduria Type IV;Beta-Ketothiolase Deficiency;Isobutyryl-coa dehydrogenase deficiency;Total 22 pathways, visit the HMDB page for details
USES
This is an endogenously produced metabolite found in the human body. It is used in metabolic reactions, catabolic reactions or waste generation.
ALIASES
REACTIONS
uspto-grants-2014_09
uspto-grants-2014_09 · 10.6084/m9.figshare.5104873.v1 · US08835443B2
查看条件与参与物uspto-grants-2014_09
uspto-grants-2014_09 · 10.6084/m9.figshare.5104873.v1 · US08835443B2
查看条件与参与物uspto-grants-2014_09
uspto-grants-2014_09 · 10.6084/m9.figshare.5104873.v1 · US08835443B2
查看条件与参与物uspto-grants-1985_05
uspto-grants-1985_05 · 10.6084/m9.figshare.5104873.v1 · US04518685
查看条件与参与物uspto-grants-1991_11
uspto-grants-1991_11 · 10.6084/m9.figshare.5104873.v1 · US05064945
查看条件与参与物uspto-grants-1987_01
uspto-grants-1987_01 · 10.6084/m9.figshare.5104873.v1 · US04636396
查看条件与参与物uspto-grants-1991_02
uspto-grants-1991_02 · 10.6084/m9.figshare.5104873.v1 · US04994363
查看条件与参与物uspto-grants-2000_12
uspto-grants-2000_12 · 10.6084/m9.figshare.5104873.v1 · US06156891
查看条件与参与物